Effects of PEMF on microcirculation and angiogenesis in a model of acute hindlimb ischemia in diabetic rats

Bioelectromagnetics

Volumn 34, Issue 3, 2013, Pages 180-188

  Pan, Yunhu ^a   Dong, Yushu ^a   Hou, Wugang ^b   Ji, Zhiyu ^a   Zhi, Kailin ^a   Yin, Zhongmin ^a   Wen, Hua ^a   Chen, Yitan ^a  

^a Department of Internal Medicine ^*  (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Diabetes; FGF 2; Hindlimb ischemia; PEMF

Indexed keywords

ASSAYS; ELECTROMAGNETIC FIELDS; MUSCLE; PHOSPHATASES; PHOSPHORYLATION;

ALKALINE PHOSPHATASE; ANGIOGENESIS; DIABETIC RATS; DIABETICS PATIENTS; FGF-2; HIND LIMBS; HINDLIMB ISCHEMIA; ISCHAEMIA; LASER DOPPLER PERFUSION IMAGING; PULSED ELECTROMAGNETIC FIELDS;

RATS;

RATTUS;

CD31 ANTIGEN; FGFR1 PROTEIN, RAT; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ELECTROMAGNETIC FIELD; EXPERIMENTAL DIABETES MELLITUS; HINDLIMB; ISCHEMIA; LASER DOPPLER FLOWMETRY; MALE; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; DIABETES MELLITUS, EXPERIMENTAL; ELECTROMAGNETIC FIELDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 84874801590     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.21755     Document Type: Article

References (21)

1. Callaghan MJ, Chang EI, Seiser N, Aarabi S, Ghali S, Kinnucan ER, Simon BJ, Gurtner GC. 2008. Pulsed electromagnetic fields accelerate normal and diabetic wound healing by increasing endogenous FGF-2 release. Plast Reconstr Surg 121:130-141.
2. Chalidia B, Sachinis N, Assiotis A, Maccauro G. 2011. Stimulation of bone formation and fracture healing with pulsed electromagnetic fields: Biologic responses and clinical implications. Int J Immunopathol Pharmacol 24:17-20.
3. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. 1998. Mouse model of angiogenesis. Am J Pathol 152:1667-1679.
4. Emanueli C, Caporali A, Krankel N, Cristofaro B, Van Linthout S, Madeddu P. 2007. Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia. Front Biosci 12:2003-2012.
5. Fam NP, Verma S, Kutryk M, Stewart DJ. 2003. Clinician guide to angiogenesis. Circulation 108:2613-2618.
6. Finetti F, Donnini S, Giachetti A, Morbidelli L, Ziche M. 2009. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circ Res 105:657-666.
7. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC. 2004. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164:1935-1947.
8. Griffin XL, Costa ML, Parsons N, Smith N. 2011. Electromagnetic field stimulation for treating delayed union or non-union of long bone fractures in adults. Cochrane Database Syst Rev 4:CD008471.
9. Goudarzi I, Hajizadeh S, Salmani ME, Abrari K. 2010. Pulsed electromagnetic fields accelerate wound healing in the skin of diabetic rats. Bioelectromagnetics 31:318-323.
10. Holmes DI, Zachary IC. 2008. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. Cell Signal 20:569-579.
11. Inoue N, Kondo T, Kobayashi K, Aoki M, Numaguchi Y, Shibuya M, Murohara T. 2007. Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler Thromb Vasc Biol 27:99-105.
12. Kawasaki K, Smith RS, Jr., Hsieh CM, Sun J, Chao J, Liao JK. 2003. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 23:5726-5737.
13. Li J, Zhao JG, Li MH. 2011. Lower limb vascular disease in diabetic patients: A study with calf compression contrast-enhanced magnetic resonance angiography at 3.0Tesla. Acad Radiol 8:755-763.
14. Nakae M, Kamiya H, Naruse K, Horio N, Ito Y, Mizubayashi R, Hamada Y, Nakashima E, Akiyama N, Kobayashi Y, Watarai A, Kimura N, Horiguchi M, Tabata Y, Oiso Y, Nakamura J. 2006. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55:1470-1477.
15. Raiter A, Bechor Z, Kleiman M, Leshem-Lev D, Battler A, Hardy B. 2010. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model. Eur J Vasc Endovasc Surg 40:381-388.
16. Rokutanda T, Izumiya Y, Miura M, Fukuda S, Shimada K, Izumi Y, Nakamura Y, Araki S, Hanatani S, Matsubara J, Nakamura T, Kataoka K, Yasuda O, Kaikita K, Sugiyama S, Kim-Mitsuyama S, Yoshikawa J, Fujita M, Yoshiyama M, Ogawa H. 2011. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb. Arterioscler Thromb Vasc Biol 31:2872-2880.
17. Scott G, King JB. 1994. A prospective, double-blind trial of electrical capacitive coupling in the treatment of non-union of long bones. J Bone Joint Surg Am 76:820-826.
18. Tepper OM, Callaghan MJ, Chang EI, Galiano RD, Bhatt KA, Baharestani S, Gan J, Simon B, Hopper RA, Levine JP, Gurtner GC. 2004. Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2. FASEB J 18:1231-1233.
19. Trivier E, Kurz DJ, Hong Y, Huang HL, Erusalimsky JD. 2004. Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: Association with replicative life span. Ann NY Acad Sci 1019:111-115.
20. Yan J, Li F, Ingram DA, Quilliam LA. 2008. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol Cell Biol 28:5803-5810.
21. Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y, Mascarelli F. 2001. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: A comparative study with VEGF. Oncogene 20:1403-1413.